300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device Startup Investors in Oceania (October 2023)

The most active venture capital funds and angel investors investing in Oceania Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Oceania Medical Device startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Brandon Capital Partners
VC Fund
7 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Medical $642k–$25M
Medical Research Commercialisation Fund (MRCF)
VC Fund
6 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Medical $1.3M–$13M
Melbourne Angels
VC Fund
4 Australia, United States, New Zealand Angel, Seed Biotechnology, Information Technology, Manufacturing $32k–$893k
Artesian VC
VC Fund
4 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $70k–$12M
Pacific Channel
VC Fund
4 New Zealand Seed, Series A Medical Device, Medical, Health Care
Global from Day One
VC Fund
3 New Zealand, United States, China Seed, Series A Software, SaaS, Medical Device $595k–$5M
Uniservices
VC Fund
3 New Zealand Seed, Pre-Seed Medical Device, SaaS, Audio
New Zealand Growth Capital Partners
VC Fund
3 New Zealand, United States Seed, Series A Software, SaaS, Manufacturing $1.3M–$6.2M
Cure Kids Ventures
VC Fund
3 New Zealand Seed, Pre-Seed, Series A Medical Device, SaaS, Medical
Icehouse Ventures
VC Fund
3 New Zealand, United States, Australia Seed, Series A Software, SaaS, Information Technology $450k–$21M
Global Health Investment Fund (GHIF)
VC Fund
2 United States, India, Austria Series B, Series C Health Care, Biotechnology, Medical Device $4.5M–$17M
IP Group
VC Fund
2 United Kingdom, United States, Australia Seed, Series A, Series B Health Care, Biotechnology, Therapeutics $369k–$61M
Allan Moss
Angel
2 Australia, United States, The Netherlands Series A, Seed Health Care, Medical Device, Biotechnology
Matū Fund
VC Fund
2 New Zealand, United States Seed Biotechnology, Robotics, Nanotechnology
Regal Funds Management
VC Fund
2 Australia, United States, United Kingdom Series B, Convertible Note Software, Financial Services, FinTech $1.6M–$25M
Punakaiki Fund
VC Fund
2 New Zealand, United States Seed, Series A, Series B Software, SaaS, Mobile Apps $355k–$5M
Uniseed Ventures
VC Fund
2 Australia, United States, United Kingdom Series A, Seed Biotechnology, Manufacturing, Health Care $364k–$6.4M
Flying Kiwis
VC Fund
2 New Zealand Seed SaaS, 3D Technology, Medical Device
K1W1
VC Fund
2 New Zealand, United States Seed, Series A Software, Biotechnology, SaaS
BridgeLane Capital
VC Fund
1 Australia, Germany Seed, Series B Software, Financial Services, Health Care $642k–$13M
HealthCare Ventures
VC Fund
1 United States, Australia, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $4.4M–$50M
Skip Capital
VC Fund
1 Australia, Canada, United States Series A, Seed, Series B Software, SaaS, Artificial Intelligence $1M–$75M
Dexcom Ventures
VC Fund
1 Australia Sensor, Medical, Wearables
Terra Rossa Capital
VC Fund
1 Australia Series A, Series B Health Care, Biotechnology, Medical Device
Movac
VC Fund
1 New Zealand, United States, Australia Seed, Series A Software, E-Commerce, SaaS $774k–$16M
Artesian Investment
Angel
1 United States, India, Australia Pre-Seed, Seed, Series A Artificial Intelligence, Agriculture, Information Technology $41k–$348k
Andrew R Banks
Angel
1 Australia Seed Grocery, Medical, Health Care $300k–$950k
Brisbane Angels
VC Fund
1 Australia, United States, New Zealand Seed, Angel Software, Information Technology, Artificial Intelligence $321k–$835k
Grand Challenges Canada
VC Fund
1 Canada, United States, Australia Grant, Seed, Debt Financing Health Care, Medical Device, Biotechnology $100k–$3.3M
Powerhouse Ventures
VC Fund
1 United States, New Zealand, The Netherlands Seed, Series A Solar, FinTech, Big Data $500k–$7M
Flying Kiwi Angels
VC Fund
1 New Zealand Angel, Seed, Pre-Seed Software, Apps, Internet $460k–$1.3M
Transition Level Investments
VC Fund
1 Australia, United States Seed, Pre-Seed, Series A SaaS, Artificial Intelligence, Software $60k–$2.4M
Versant Ventures
VC Fund
1 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $3.9M–$85M
Tuhua Fund
VC Fund
1 New Zealand, Singapore, United States Seed, Series A, Angel Software, Internet, B2B $735k–$4.8M
Sydney Angels
VC Fund
1 Australia, United States Seed, Angel Software, SaaS, Apps $161k–$895k
Blackbird Ventures
VC Fund
1 Australia, United States, New Zealand Seed, Series A, Series B Software, SaaS, Information Technology $29k–$28M
Horizons Ventures
VC Fund
1 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Artificial Intelligence, Software $750k–$70M
Bridgewest Group
VC Fund
1 New Zealand, United States Seed Mobile, Hardware, Internet
GD1
VC Fund
1 New Zealand Seed, Series A, Series B Software, Machine Learning, SaaS
New Zealand Venture Investment Fund
VC Fund
1 New Zealand, United States, Japan Seed, Series A, Angel Software, Biotechnology, SaaS $400k–$8.5M
Playford Capital
VC Fund
1 Australia Series A, Series B Health Care, Biotechnology, Medical Device
Victoria University of Wellington
VC Fund
1
OneVentures
VC Fund
1 Australia, United States, Israel Series A, Debt Financing Software, Health Care, Information Technology $1.5M–$20M
CP Ventures
VC Fund
1 Australia, United States, India Seed, Pre-Seed, Series A Software, Artificial Intelligence, Machine Learning $364k–$12M
Quayside Holdings
VC Fund
1 New Zealand Seed, Series B Sensor, FinTech, Hardware
Topcon Healthcare
VC Fund
1 New Zealand Series A Health Care, Medical Device, Health Diagnostics
UniSA Ventures
VC Fund
1 Australia Seed Software, Health Care, Biotechnology
Ramsay Health Care
VC Fund
1 Australia Series A Medical, Health Care, Medical Device
VU Venture Partners
VC Fund
1 United States, Colombia, India Seed, Series A Software, Health Care, Machine Learning $120k–$57M
Bay Trust
VC Fund
1 New Zealand Seed Sensor, Hardware, Robotics
Access all 50 investors in Oceania Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Brandon Capital Partners
VC Fund · Melbourne, Victoria, Australia · 7 investments in Oceania Medical Device startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 39
  • Round size: Seed $642k–$6.4M; Series A $4M–$20M; Series B $5M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2019

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show all investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia · 6 investments in Oceania Medical Device startups

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 25
  • Round size: Series A $1.3M–$13M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show all investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia · 4 investments in Oceania Medical Device startups

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Manufacturing
  • Stage:Angel, Seed
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 34
  • Round size: Seed $32k–$771k; Angel $601k–$893k
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Tayble — Spend more time enjoying your food and less time waiting.We hate waiting...For anything...And food and drinks are no exception!If your hobbies include:- Waiting in line - Calling out to a waiter - Watching the kettle boil - Calculating your split of the billPLEASE DO NOT DOWNLOAD THIS APP... YOU'LL HATE IT!But if you're likeus...And want your food and drinks ready exactly when you are...Or to leave a restaurant without worrying about your bill...Then step right up, this bad boy's for you!With Tayble, you’ll never have to flag down a waiter... EVER!Simply order from your "Tayble"Or before you even arrive...Leave the rest to us and the 1,000's of minions in the cloud that keep this all running!You’ll be left asking where has this been all my life, guaranteed!*(Definitely not a real guarantee)
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 4 investments in Oceania Medical Device startups, 13 in the past 12 months

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 172
  • Round size: Seed $96k–$2.4M; Pre-Seed $70k–$1.5M; Series A $3.3M–$12M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show all investments...

Pacific Channel
VC Fund · Auckland, Auckland, New Zealand · 4 investments in Oceania Medical Device startups

Investing in great people solving hard problems to create a better future.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: New Zealand

Investor stats

  • Total investments: 8
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Orbica — Orbica develops innovative, cross-industry location data solutions, services and products.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Global from Day One
VC Fund · Auckland, Auckland, New Zealand · 3 investments in Oceania Medical Device startups

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Industry: Software, SaaS, Medical Device
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, China

Investor stats

  • Total investments: 27
  • Round size: Seed $595k–$5M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

Uniservices
VC Fund · 3 investments in Oceania Medical Device startups

Auckland University's commercialisation arm

Show more...

Investment focus

  • Industry: Medical Device, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

New Zealand Growth Capital Partners
VC Fund · 3 investments in Oceania Medical Device startups

The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.

Show more...

Investment focus

  • Industry: Software, SaaS, Manufacturing
  • Stage:Seed, Series A
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$6.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Cure Kids Ventures
VC Fund · Auckland, Auckland, New Zealand · 3 investments in Oceania Medical Device startups

Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to

Show more...

Investment focus

  • Industry: Medical Device, SaaS, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: New Zealand

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Icehouse Ventures
VC Fund · Auckland, Auckland, New Zealand · 3 investments in Oceania Medical Device startups, 14 in the past 12 months

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, Australia

Investor stats

  • Total investments: 125
  • Round size: Seed $450k–$2.6M; Series A $1.4M–$21M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • DataMasque — Simply mask your sensitive data while maintaining its function for testing, development, training and analytics. DataMasque makes it safe to explore, implement and harness the opportunities that data provides, free from privacy concerns or compromise.
  • Aquila — We're powering the future by building and operating an infinitely scalable energy network.
  • Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States · 2 investments in Oceania Medical Device startups

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series B, Series C
  • Geography: United States, India, Austria

Investor stats

  • Total investments: 18
  • Round size: Series B $7.5M–$17M; Series C $4.5M–$14M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 2 investments in Oceania Medical Device startups, 9 in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 157
  • Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Allan Moss
Angel · Sydney, New South Wales, Australia · 2 investments in Oceania Medical Device startups

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Series A, Seed
  • Geography: Australia, United States, The Netherlands

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Show all investments...

Matū Fund
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical Device startups

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Nanotechnology
  • Stage:Seed
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 7
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ligar — Novel technology to rapidly and cost effectively capture and recover specific molecules or groups of molecules from liquids, such as bioactives, bitter flavours or contaminants from natural extracts, wine, water, juices, coffee and wastewater. [et_pb_column type="1_3"
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Show all investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical Device startups

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Series B, Convertible Note
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 71
  • Round size: Series B $7M–$25M; Convertible Note $1.6M–$16M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $48M in 2022

Portfolio highlights

  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • SendFX — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Show all investments...

Punakaiki Fund
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical Device startups

Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.

Show more...

Investment focus

  • Industry: Software, SaaS, Mobile Apps
  • Stage:Seed, Series A, Series B
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 12
  • Round size: Seed $355k–$5M; Series A $1.5M–$3M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Whip Around — Providing fleet maintenance software that automates preventive maintenance tasks, improves inspections, tracks work orders, and manages your fleet health.
  • projectworks — Project Works is a cloud based workforce management platform designed to help professional & creative services businesses better manage their organisations in the areas of project management, project financials, and people management. Our mission is to provide a platform that enables world class services businesses to get the most out of theirexisting workforce, and enable them to grow.
Show all investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 2 investments in Oceania Medical Device startups

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 56
  • Round size: Seed $364k–$2M; Series A $1.3M–$6.4M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $13M in 2017

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Show all investments...

Flying Kiwis
VC Fund · 2 investments in Oceania Medical Device startups

Super-seeded by new entry: Flying Kiwi Angels

Show more...

Investment focus

  • Industry: SaaS, 3D Technology, Medical Device
  • Stage:Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

K1W1
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical Device startups, 6 in the past 12 months

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Series A
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 61
  • Lead/follow: no public data

Portfolio highlights

  • Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show all investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Industry: Software, Financial Services, Health Care
  • Stage:Seed, Series B
  • Geography: Australia, Germany

Investor stats

  • Total investments: 16
  • Round size: Seed $642k–$2M; Series B $5M–$13M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HealthCare Ventures
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Oceania Medical Device startups

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Australia, United Kingdom

Investor stats

  • Total investments: 102
  • Round size: Series A $4.4M–$37M; Series B $10M–$50M; Series C $10M–$44M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — last raise in 2010

Portfolio highlights

  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Show all investments...

Skip Capital
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups

Skip Capital is a private investment fund investing in technology and infrastructure

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: Australia, Canada, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $1M–$7.1M; Series A $1M–$75M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Neara — Neara electric utility software is a physics-enabled platform that builds 3D interactive models of critical infrastructure networks and assets. Request a demo.
  • Human — Human aims to assist medical professionals and patients to make more statistics selections.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
Show all investments...

Dexcom Ventures
VC Fund · San Diego, California, United States · 1 investments in Oceania Medical Device startups

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

Show more...

Investment focus

  • Industry: Sensor, Medical, Wearables
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
Show all investments...

Terra Rossa Capital
VC Fund · Adelaide, South Australia, Australia · 1 investments in Oceania Medical Device startups

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Australia

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show all investments...

Movac
VC Fund · Wellington, Wellington, New Zealand · 1 investments in Oceania Medical Device startups

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

Show more...

Investment focus

  • Industry: Software, E-Commerce, SaaS
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, Australia

Investor stats

  • Total investments: 30
  • Round size: Seed $1.4M–$4.3M; Series A $774k–$16M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Atomic — Atomic embeds native, actionable customer interaction inside your iOS, Android or web app. Turn your customer data and insights into loyalty, retention and conversion.
  • ZeroJet — ZeroJet is the first jet propulsion system to be designed specifically for an electric motor, delivering the perfect balance of performance and runtime.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show all investments...

Artesian Investment
Angel · 1 investments in Oceania Medical Device startups

Artesian Investment

Show more...

Investment focus

  • Industry: Artificial Intelligence, Agriculture, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, India, Australia

Investor stats

  • Total investments: 9
  • Round size: Pre-Seed $41k–$348k
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
  • LYRO Robotics — A robotic packing solution for fruits and vegetables
  • HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Show all investments...

Andrew R Banks
Angel · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups

Andrew R Banks

Show more...

Investment focus

  • Industry: Grocery, Medical, Health Care
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 2
  • Round size: Seed $300k–$950k
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
  • CancerAid — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
Show all investments...

Brisbane Angels
VC Fund · Brisbane, Queensland, Australia · 1 investments in Oceania Medical Device startups

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Angel
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 28
  • Round size: Seed $347k–$835k; Angel $321k–$601k
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Tribu — Here at tribu we aim to make running an MSP stress-free and simple. Remove complexity and repetitive shackles to give you the freedom in business so that you can have freedom in life.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
Show all investments...

Grand Challenges Canada
VC Fund · Toronto, Ontario, Canada · 1 investments in Oceania Medical Device startups

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Grant, Seed, Debt Financing
  • Geography: Canada, United States, Australia

Investor stats

  • Total investments: 11
  • Round size: Grant $100k–$3.3M; Debt Financing $726k–$2M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
  • Nivi, Inc. — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
  • Sensoreal — Sensoreal Inc. is a diagnostic device and service provider company. The company is developing a variety of biosensors, which can perform one-step immunoassays in low-cost, accurate and quantifiable manners. Sensoreal was founded in 2014, and is headquartered in Montreal, Canada.
Show all investments...

Powerhouse Ventures
VC Fund · Christchurch, Canterbury, New Zealand · 1 investments in Oceania Medical Device startups

powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures

Show more...

Investment focus

  • Industry: Solar, FinTech, Big Data
  • Stage:Seed, Series A
  • Geography: United States, New Zealand, The Netherlands

Investor stats

  • Total investments: 5
  • Round size: Series A $500k–$7M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Granular — Granular is a start-up providing market solutions for 24/7 clean energy.
  • Salient Predictions — Salient Predictions uses ML & ocean data to provide long range weather forecast for use in diverse industries.
  • Energetic Insurance — Let us cover the payment default risk on your next Solar Project. Energetic Insurance makes efficient financing possible for financiers, investors and energy service providers with the EneRate Credit Cover solar insurance policy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Flying Kiwi Angels
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical Device startups

Flying Kiwi Angels ? Helping Kiwi Startups

Show more...

Investment focus

  • Industry: Software, Apps, Internet
  • Stage:Angel, Seed, Pre-Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 10
  • Round size: Angel $595k–$893k; Pre-Seed $460k–$1.3M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • FileInvite — The simplest, most secure, document collection platform for professionals. Request files, forms, data and e-signatures all through a secure client portal.
  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Well Revolution — Online doctors, prescriptions, advice & treatment in NZ. Chat privately with a GP at the touch of a button for same-day consults & pharmacy prescriptions.
Show all investments...

Transition Level Investments
VC Fund · Brisbane, Queensland, Australia · 1 investments in Oceania Medical Device startups

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

Show more...

Investment focus

  • Industry: SaaS, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 17
  • Round size: Seed $835k–$2.4M; Pre-Seed $60k–$1.5M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 1 investments in Oceania Medical Device startups, 7 in the past 12 months

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 253
  • Round size: Series A $3.9M–$68M; Series B $6M–$85M; Series C $6M–$80M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Kate Therapeutics — Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
  • Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
  • Tentarix Biotherapeutics — Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Show all investments...

Tuhua Fund
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical Device startups

Micro-Venture Fund investing in 25 Kiwi Startups

Show more...

Investment focus

  • Industry: Software, Internet, B2B
  • Stage:Seed, Series A, Angel
  • Geography: New Zealand, Singapore, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $735k–$3.2M; Series A $1.4M–$4.8M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $6.5M in 2016

Portfolio highlights

  • Datch — Built on top of a powerful connected platform, the Datch Voice Assistant allows you to use the most natural form of communication - your voice - to converse with your site, allowing you to connect and interact with your existing in-house systems through simple integrations.
  • Dawn Aerospace — Delivering hardware to space. Positioning satellites on orbit. Returning products to Earth.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Show all investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Industry: Software, SaaS, Apps
  • Stage:Seed, Angel
  • Geography: Australia, United States

Investor stats

  • Total investments: 42
  • Round size: Seed $161k–$895k; Angel $330k–$890k
  • Lead/follow: 60% lead, 40% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek is the drone data solution asset managers use to make empowered decisions and ensure absolute asset knowledge. Conduct complete visual inspections from any web browser. Extract detailed insights without a site visit. Use powerful tools to analyse the structure and build a complete picture of asset condition. Enhance predictive maintenanceby closely monitoring trends. View different models side by side to observe important differences. Refine your understanding of an ever-changing asset.
Show all investments...

Blackbird Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups, 27 in the past 12 months

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 221
  • Round size: Seed $29k–$1.7M; Series A $3.2M–$15M; Series B $7M–$28M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Marqo — A tensor-based search and analytics engine that seamlessly integrates with your applications, websites, and workflows.
  • BioticsAI — Advancing Fetal Ultrasound Screenings Using AI
  • Kiki — Kiki is a subletting startup that matches listers with people looking to rent for up to six months.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Oceania Medical Device startups, 17 in the past 12 months

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 216
  • Round size: Seed $750k–$11M; Series A $6M–$30M; Series B $8M–$70M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
  • Erthos — erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
  • ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Show all investments...

Bridgewest Group
VC Fund · San Diego, California, United States · 1 investments in Oceania Medical Device startups

Bridgewest Group is a closely held investment company with global assets in the biotech, wireless communications, infrastructure for "internet of things," semiconductor, real estate, and financial services industries.

Show more...

Investment focus

  • Industry: Mobile, Hardware, Internet
  • Stage:Seed
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Gimbal — Gimbal develops and delivers mobile contextual awareness platform and solutions to enhance mobile engagement. Using its own hardware and software, Gimbal enables brands, media agencies, and marketers to improve their campaigns with personalized messaging and drive measurable business outcomes. The company offers Gimbal, a geofencing and analyticsplatform; AdSynergy, AdKit, AdCast, AdScore, AudienceArchitect, for mobile media campaigns; people and proximity platform, such as Gimbal Manager, GeoFences, and Location SDK, for cloud-based location management; and Bluetooth smart beacons with iBeacon technology.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Show all investments...

GD1
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical Device startups

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Industry: Software, Machine Learning, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: New Zealand

Investor stats

  • Total investments: 7
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Formus Labs — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • StretchSense — The StretchSense hand motion capture solution brings together accurate and comfortable gloves, and machine learning to detect and render perfect hand poses. - StretchSense
  • Zenno Astronautics — At Zenno Astronautics, our hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Show all investments...

New Zealand Venture Investment Fund
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical Device startups

Your guide to finding and using government services.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Series A, Angel
  • Geography: New Zealand, United States, Japan

Investor stats

  • Total investments: 35
  • Round size: Seed $417k–$1.2M; Angel $400k–$417k; Series A $1.4M–$8.5M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Playford Capital
VC Fund · Adelaide, South Australia, Australia · 1 investments in Oceania Medical Device startups

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Australia

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show all investments...

Victoria University of Wellington
VC Fund · Wellington, Wellington, New Zealand · 1 investments in Oceania Medical Device startups

A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.

Show more...

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show all investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups, 6 in the past 12 months

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Debt Financing
  • Geography: Australia, United States, Israel

Investor stats

  • Total investments: 64
  • Round size: Series A $1.5M–$20M; Debt Financing $1.8M–$4M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $128M in 2022

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
Show all investments...

CP Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups

CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States, India

Investor stats

  • Total investments: 52
  • Round size: Seed $364k–$4M; Pre-Seed $800k–$900k; Series A $5.1M–$12M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Anility — Embed financial health insights within your application using our world leading API service
  • Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
  • Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Show all investments...

Quayside Holdings
VC Fund · 1 investments in Oceania Medical Device startups

Quayside Holdings is the investment arm of the Bay of Plenty Regional Council which responsibly manages the commercial, property and horticulture investments.

Show more...

Investment focus

  • Industry: Sensor, FinTech, Hardware
  • Stage:Seed, Series B
  • Geography: New Zealand

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • TradeWindow — TradeWindow provides the tools and support for exporters, importers, freight forwarders, and customs brokers to begin the journey to digital transformation.
  • WNT Ventures — New Zealand's Venture Capital Deep Tech Investor. Investing in Deeptech founders from Aotearoa to build local companies and help them go global
Show all investments...

Topcon Healthcare
VC Fund · Oakland, New Jersey, United States · 1 investments in Oceania Medical Device startups

Topcon Healthcare empowers providers with advanced imaging, diagnostic solutions and intelligent data technology, offering a more fully integrated approach to diagnosis and treatment in eyecare.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Health Diagnostics
  • Stage:Series A
  • Geography: New Zealand

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Toku Eyes — Instant Healthcare Diagnostics. Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics...
Show all investments...

UniSA Ventures
VC Fund · 1 investments in Oceania Medical Device startups

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — All-in-one productivity tool for teams & individuals.
Show all investments...

Ramsay Health Care
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical Device startups

Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Show all investments...

VU Venture Partners
VC Fund · San Francisco, California, United States · 1 investments in Oceania Medical Device startups

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

Show more...

Investment focus

  • Industry: Software, Health Care, Machine Learning
  • Stage:Seed, Series A
  • Geography: United States, Colombia, India

Investor stats

  • Total investments: 85
  • Round size: Seed $120k–$6M; Series A $5.7M–$57M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Show all investments...

Bay Trust
VC Fund · 1 investments in Oceania Medical Device startups

Community Trust

Show more...

Investment focus

  • Industry: Sensor, Hardware, Robotics
  • Stage:Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • WNT Ventures — New Zealand's Venture Capital Deep Tech Investor. Investing in Deeptech founders from Aotearoa to build local companies and help them go global
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device Investors in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Oceania Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists